Analysts Set Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Target Price at $52.44
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) has earned a consensus recommendation of “Buy” from the nine analysts that are presently covering the company, Marketbeat.com reports. Nine investment analysts have rated the stock with a buy recommendation. The average twelve-month target price among brokers that have updated their coverage on the stock in […]
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) has earned a consensus recommendation of “Buy” from the nine analysts that are presently covering the company, Marketbeat.com reports. Nine investment analysts have rated the stock with a buy recommendation. The average twelve-month target price among brokers that have updated their coverage on the stock in […]
